Vitamin D2, Muscle Damage, NASCAR Pitcrew

Sponsor
Appalachian State University (Other)
Overall Status
Completed
CT.gov ID
NCT01825616
Collaborator
Dole Food Company (Industry)
33
3
2
3
11
3.6

Study Details

Study Description

Brief Summary

Hypothesis: Six weeks of supplementation with vitamin D (4000 IU/day) using Dole's Vitamin D Portobello Mushroom Powder will increase winter serum vitamin D levels, and improve muscle function and strength, and innate immunity (granulocyte/monocyte phagocytosis and oxidative burst activity), and attenuate exercise-induced muscle damage and DOMS.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Vitamin D2 mushroom powder
  • Other: Placebo
N/A

Detailed Description

Vitamin D2 is found naturally in sun-exposed mushrooms, and vitamin D3 is synthesized in the skin when exposed to sunlight and is present in oil-rich fish such as salmon, mackerel, and herring. Mushrooms contain very little or any vitamin D2 but are abundant in ergosterol, which can be converted into vitamin D2 by ultraviolet (UV) illumination (Eur J Clin Nutr. 2011;65:965-71).

In recent decades, there has been increased awareness of the impact of vitamin D on muscle function (Scand J Med Sci Sports. 2010;20:182-90). In the early 20th century, athletes and coaches felt that ultraviolet rays had a positive impact on athletic performance, and evidence is accumulating to support this view. Both cross-sectional and longitudinal studies support a functional role for vitamin D in muscle, and the discovery of the vitamin D receptor in muscle tissue provides a mechanistic pathway for understanding the role of vitamin D within muscle. Studies in athletes have found that vitamin D status is variable and is dependent on outdoor training time (during peak sunlight), skin color, and geographic location (Pediatr Clin North Am. 2010;57:849-61).

25(OH)D is the best indicator and major form of vitamin D in the blood, with a circulating half-life of 2-3 weeks. Vitamin D deficiency is defined as a plasma vitamin D [25(OH)D] level of less than 20 ng/ml, with vitamin D insufficiency defined as 21-29 ng/ml. Estimates are that 20-100% of children, young and middle-aged adults, and community-dwelling elderly men and women are vitamin D deficient (J Clin Endocrinol Metab. 2011;96:1911-30).

Purpose: To determine if 6 weeks supplementation with Dole Vitamin D Portobello Mushroom Powder (4,000 IU/day) can, 1) increase winter serum vitamin D levels, and measure whether vitamin D supplementation 2) has a chronic influence on muscle function and strength, and innate immune function, and 3) can attenuate exercise-induced muscle damage and delayed onset of muscle soreness (DOMS) in athletes.

Study Design

Study Type:
Interventional
Actual Enrollment :
33 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Influence of 6-weeks Supplementation With Vitamin D Portobello Mushroom Powder on Muscle Function and Performance, Innate Immune Function, and Exercise-induced Muscle Damage and DOMS in NASCAR Pit Crew Members
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vitamin D2 mushroom powder

4000 IU/day vitamin D2 mushroom powder

Dietary Supplement: Vitamin D2 mushroom powder
Subjects will be given Portobello mushroom powder with or without vitamin D mixed in soymilk powder in six plastic containers (one for each week of the study). Subjects will ingest one level teaspoon of the product each day (with or without 4,000 IU vitamin D2) and consume during breakfast in one of the following ways: mixed in water, juice, yogurt, or milk.
Other Names:
  • UV radiated Portobello mushroom powder
  • Placebo Comparator: Placebo

    Mushroom powder without vitamin D2 (not exposed to UV radiation)

    Other: Placebo
    Mushroom powder without vitamin D2

    Outcome Measures

    Primary Outcome Measures

    1. Muscle damage [6 weeks]

      myoglobin (ug/L) and creatine kinase (IU/L) after eccentric resistance exercise

    2. Muscle Function [6 weeks]

      Bench press of body weight, reps to fatigue Vertical jump (watts( 300 yard shuttle run (seconds) 30-sec Wingate anaerobic power test (watts/kg)

    Secondary Outcome Measures

    1. Serum vitamin D concentration [6 weeks]

      25(OH)D2 and 25(OH)D3

    2. Immune Function [6 weeks]

      White blood cell differential Myeloperoxidase Immune cell cytotoxicity

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 40 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • NASCAR pit crew members

    • Willing to avoid food and supplement sources (during the 6-week supplementation period) that are high in vitamin D (specifically canned fish, cod liver oil, salmon, and supplements with high-dose vitamin D).

    • Agree to train normally.

    • Avoid the use of large dose vitamin/mineral supplements (above 100% recommended dietary allowances), and medications known to affect immune function.

    • Avoid the use of tanning beds.

    • Willing to adhere to all aspects of the study design.

    Exclusion Criteria:
    • Not allergic to mushrooms.

    • Do not have a heart problem or have been told by your doctor not to engage in vigorous exercise.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ASU Human Performance Laboratory, North Carolina Research Campus Kannapolis North Carolina United States 28081
    2 ASU-NCRC Human Performance Laboratory Kannapolis North Carolina United States 28081
    3 ASU-NCRC Human Performance Lab Kannapolis North Carolina United States 28081

    Sponsors and Collaborators

    • Appalachian State University
    • Dole Food Company

    Investigators

    • Principal Investigator: David C Nieman, DrPH, Appalachian State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Appalachian State University
    ClinicalTrials.gov Identifier:
    NCT01825616
    Other Study ID Numbers:
    • 12_0355
    First Posted:
    Apr 5, 2013
    Last Update Posted:
    Apr 9, 2013
    Last Verified:
    Apr 1, 2013
    Keywords provided by Appalachian State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 9, 2013